Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 12, 2017 Filed May 15, 2017 20:45 UTC |
BEVERIDGE, ROY ASr. VP & Chief Medical Officer
|
Tax withholdingHumana Common | 1,281 | $229.77 | $294,328.97 |
DisclosureSEC source: 0000049071-17-000117 · edgar.xml · nonDerivative · entry 4 BEVERIDGE, ROY A · CIK 0001579300 · Sr. VP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,003 F10 · price: Shares swapped for payment of purchase price on incentive stock option exercises using fair market value on May 11, 2017, pursuant to Humana Inc.'s 2011 Stock Incentive Plan. Read SEC document |
| May 12, 2017 Filed May 15, 2017 20:45 UTC |
BEVERIDGE, ROY ASr. VP & Chief Medical Officer
|
Exercise / conversionHumana Common | 26,023 | $231.99 | $6,037,172.06 |
DisclosureSEC source: 0000049071-17-000117 · edgar.xml · nonDerivative · entry 3 BEVERIDGE, ROY A · CIK 0001579300 · Sr. VP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,284 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · price: Shares sold at prices ranging from $231.88 to $232.10. Read SEC document |
| May 12, 2017 Filed May 15, 2017 20:45 UTC |
BEVERIDGE, ROY ASr. VP & Chief Medical Officer
|
Exercise / conversionHumana Common | 15,086 | $102.16 | $1,541,110.33 |
DisclosureSEC source: 0000049071-17-000117 · edgar.xml · nonDerivative · entry 2 BEVERIDGE, ROY A · CIK 0001579300 · Sr. VP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,037 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2017 Filed May 15, 2017 20:45 UTC |
BEVERIDGE, ROY ASr. VP & Chief Medical Officer
|
Exercise / conversionHumana Common | 14,290 | $81.80 | $1,168,850.55 |
DisclosureSEC source: 0000049071-17-000117 · edgar.xml · nonDerivative · entry 1 BEVERIDGE, ROY A · CIK 0001579300 · Sr. VP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,221 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2017 Filed May 9, 2017 17:47 UTC |
BILNEY JODY LSVP & Chief Consumer Officer
|
SaleHumana Common | 4,600 | $230.16 | $1,058,743.36 |
DisclosureSEC source: 0000049071-17-000110 · edgar.xml · nonDerivative · entry 1 BILNEY JODY L · CIK 0001185995 · SVP & Chief Consumer Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,978 F8 · price: All shares sold at this price. Read SEC document |
| May 04, 2017 Filed May 4, 2017 20:05 UTC |
Huval Timothy S.Senior VP & Chief HR Officer
|
Exercise / conversionOptions · Derivative | 6,934 | $0.00 Strike: $167.81 | $0.00 |
DisclosureSEC source: 0000049071-17-000107 · edgar.xml · derivative · entry 5 Huval Timothy S. · CIK 0001565717 · Senior VP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,870 Underlying: Humana Common · 6,934 shares Expires 2023-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/16, vesting in three increments from 02/18/17 to 02/18/19. F2 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/16, vesting in three increments from 02/18/17 to 02/18/19. Read SEC document |
| May 04, 2017 Filed May 4, 2017 20:05 UTC |
Huval Timothy S.Senior VP & Chief HR Officer
|
Exercise / conversionOptions · Derivative | 7,005 | $0.00 Strike: $164.65 | $0.00 |
DisclosureSEC source: 0000049071-17-000107 · edgar.xml · derivative · entry 4 Huval Timothy S. · CIK 0001565717 · Senior VP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,005 Underlying: Humana Common · 7,005 shares Expires 2022-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Right to buy pursuant to the Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/15, vesting in three increments from 02/24/16 to 02/24/18. F1 · derivative.exercise_date: Right to buy pursuant to the Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/15, vesting in three increments from 02/24/16 to 02/24/18. Read SEC document |
| May 04, 2017 Filed May 4, 2017 20:05 UTC |
Huval Timothy S.Senior VP & Chief HR Officer
|
SaleHumana Common | 13,939 | $225.86 | $3,148,305.75 |
DisclosureSEC source: 0000049071-17-000107 · edgar.xml · nonDerivative · entry 3 Huval Timothy S. · CIK 0001565717 · Senior VP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,634 F7 · price: Shares sold at prices ranging from $225.10 to $226.67. Price reported is the average sale price. Read SEC document |
| May 04, 2017 Filed May 4, 2017 20:05 UTC |
Huval Timothy S.Senior VP & Chief HR Officer
|
Exercise / conversionHumana Common | 6,934 | $167.81 | $1,163,559.87 |
DisclosureSEC source: 0000049071-17-000107 · edgar.xml · nonDerivative · entry 2 Huval Timothy S. · CIK 0001565717 · Senior VP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,573 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2017 Filed May 4, 2017 20:05 UTC |
Huval Timothy S.Senior VP & Chief HR Officer
|
Exercise / conversionHumana Common | 7,005 | $164.65 | $1,153,338.23 |
DisclosureSEC source: 0000049071-17-000107 · edgar.xml · nonDerivative · entry 1 Huval Timothy S. · CIK 0001565717 · Senior VP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,639 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2017 Filed May 4, 2017 20:04 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
Exercise / conversionOptions · Derivative | 39,147 | $0.00 Strike: $167.81 | $0.00 |
DisclosureSEC source: 0000049071-17-000106 · edgar.xml · derivative · entry 5 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,294 Underlying: Humana Common · 39,147 shares Expires 2023-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/16, vesting in three increments from 02/18/17 to 02/18/19. F2 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/16, vesting in three increments from 02/18/17 to 02/18/19. Read SEC document |
| May 04, 2017 Filed May 4, 2017 20:04 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
Exercise / conversionOptions · Derivative | 79,084 | $0.00 Strike: $164.65 | $0.00 |
DisclosureSEC source: 0000049071-17-000106 · edgar.xml · derivative · entry 4 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,542 Underlying: Humana Common · 79,084 shares Expires 2022-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Right to buy pursuant to the Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to Reporting Person on 02/24/15, vesting in three increments from 02/24/16 to 02/24/18. F1 · derivative.exercise_date: Right to buy pursuant to the Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to Reporting Person on 02/24/15, vesting in three increments from 02/24/16 to 02/24/18. Read SEC document |
| May 04, 2017 Filed May 4, 2017 20:04 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
SaleHumana Common | 118,231 | $225.82 | $26,699,149.06 |
DisclosureSEC source: 0000049071-17-000106 · edgar.xml · nonDerivative · entry 3 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,086 F7 · price: Shares sold at prices ranging from $224.65 to $228.71. Price reported is the average sale price. Read SEC document |
| May 04, 2017 Filed May 4, 2017 20:04 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
Exercise / conversionHumana Common | 39,147 | $167.81 | $6,569,062.34 |
DisclosureSEC source: 0000049071-17-000106 · edgar.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,317 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2017 Filed May 4, 2017 20:04 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
Exercise / conversionHumana Common | 79,084 | $164.65 | $13,020,785.18 |
DisclosureSEC source: 0000049071-17-000106 · edgar.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,170 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2017 Filed Apr 3, 2017 21:05 UTC |
MURRAY JAMES EEVP & COO
|
OtherPhantom Stock Units · Derivative | 5 | $201.66 | $1,008.30 |
DisclosureSEC source: 0000049071-17-000090 · edgar.xml · derivative · entry 7 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 205 Underlying: Humana Common · 5 shares Expires not disclosed F7 · security: Phantom Stock Units held for the benefit of reporting person as of March 31, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. F7 · derivative.exercise_price: Phantom Stock Units held for the benefit of reporting person as of March 31, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. F7 · derivative.exercise_date: Phantom Stock Units held for the benefit of reporting person as of March 31, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. F7 · derivative.expiration_date: Phantom Stock Units held for the benefit of reporting person as of March 31, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. F7 · ownership.nature: Phantom Stock Units held for the benefit of reporting person as of March 31, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 20:21 UTC |
HILZINGER KURT JDirector
|
GrantStock Unit · Derivative | 371 | $206.42 | $76,581.82 |
DisclosureSEC source: 0000049071-17-000092 · edgar.xml · derivative · entry 4 HILZINGER KURT J · CIK 0001191504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,195 Underlying: Humana Common · 371 shares Expires not disclosed F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 20:16 UTC |
McDonald William J.Director
|
GrantStock Unit · Derivative | 150 | $206.42 | $30,963.00 |
DisclosureSEC source: 0000049071-17-000091 · edgar.xml · derivative · entry 3 McDonald William J. · CIK 0001415604 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,996 Underlying: Humana Common · 150 shares Expires not disclosed F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Read SEC document |
| March 30, 2017 Filed Apr 3, 2017 21:05 UTC |
MURRAY JAMES EEVP & COO
|
GiftHumana Common | 121 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000090 · edgar.xml · nonDerivative · entry 1 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,668 Read SEC document |
| March 21, 2017 Filed Mar 22, 2017 17:01 UTC |
BILNEY JODY LSVP & Chief Consumer Officer
|
SaleHumana Common | 4,348 | $213.80 | $929,619.79 |
DisclosureSEC source: 0000049071-17-000085 · edgar.xml · nonDerivative · entry 1 BILNEY JODY L · CIK 0001185995 · SVP & Chief Consumer Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,578 F8 · price: All shares sold at this price. Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 20:47 UTC |
Zipperle Cynthia HVice President, CAO,Controller
|
OtherPhantom Stock Units · Derivative | 6 | $213.55 | $1,281.30 |
DisclosureSEC source: 0000049071-17-000088 · edgar.xml · derivative · entry 7 Zipperle Cynthia H · CIK 0001628102 · Vice President, CAO,Controller 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 243 Underlying: Humana Common · 6 shares Expires not disclosed F7 · security: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. F7 · derivative.exercise_price: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. F7 · derivative.exercise_date: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. F7 · derivative.expiration_date: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. F7 · ownership.nature: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 20:46 UTC |
MURRAY JAMES EEVP & COO
|
OtherPhantom Stock Units · Derivative | 200 | $213.55 | $42,710.00 |
DisclosureSEC source: 0000049071-17-000087 · edgar.xml · derivative · entry 7 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 200 Underlying: Humana Common · 200 shares Expires not disclosed F7 · security: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. F7 · derivative.exercise_price: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. F7 · derivative.exercise_date: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. F7 · derivative.expiration_date: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. F7 · ownership.nature: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 20:39 UTC |
Wheatley Timothy AlanPresident, Retail Segment
|
OtherPhantom Stock Units · Derivative | 3 | $213.55 | $640.65 |
DisclosureSEC source: 0000049071-17-000086 · edgar.xml · derivative · entry 9 Wheatley Timothy Alan · CIK 0001699799 · President, Retail Segment 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 108 Underlying: Humana Common · 3 shares Expires not disclosed F9 · security: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. F9 · derivative.exercise_price: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. F9 · derivative.exercise_date: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. F9 · derivative.expiration_date: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. F9 · ownership.nature: Phantom Stock Units held for the benefit of reporting person as of March 21, 2017 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Read SEC document |
| March 17, 2017 Filed Mar 21, 2017 16:09 UTC |
Kay Christopher E.SVP & Chief Innovation Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,929 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000080 · edgar.xml · derivative · entry 6 KAY CHRISTOPHER E · CIK 0001602570 · SVP & Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 2,929 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_date: Restricted stock units granted to Reporting Person on 03/17/14, 100% of the award is vesting on 03/17/17. F5 · derivative.expiration_date: Restricted stock units granted to Reporting Person on 03/17/14, 100% of the award is vesting on 03/17/17. Read SEC document |
| March 17, 2017 Filed Mar 21, 2017 16:09 UTC |
Kay Christopher E.SVP & Chief Innovation Officer
|
Tax withholdingHumana Common | 2,502 | $218.82 | $547,481.39 |
DisclosureSEC source: 0000049071-17-000080 · edgar.xml · nonDerivative · entry 2 KAY CHRISTOPHER E · CIK 0001602570 · SVP & Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,335 Read SEC document |
| March 17, 2017 Filed Mar 21, 2017 16:09 UTC |
Kay Christopher E.SVP & Chief Innovation Officer
|
Exercise / conversionHumana Common | 6,134 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000080 · edgar.xml · nonDerivative · entry 1 KAY CHRISTOPHER E · CIK 0001602570 · SVP & Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,837 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · balance_after: Includes both time based (2,929) and performance based (3,205) restricted stock units that vested on 3/17/17. Read SEC document |
| March 17, 2017 Filed Mar 27, 2017 14:22 UTC Amendment |
Kay Christopher E.SVP & Chief Innovation Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,929 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000089 · edgar.xml · derivative · entry 6 KAY CHRISTOPHER E · CIK 0001602570 · SVP & Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 2,929 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_date: Restricted stock units granted to Reporting Person on 03/17/14, 100% of the award is vesting on 03/17/17. F5 · derivative.expiration_date: Restricted stock units granted to Reporting Person on 03/17/14, 100% of the award is vesting on 03/17/17. Read SEC document |
| March 17, 2017 Filed Mar 27, 2017 14:22 UTC Amendment |
Kay Christopher E.SVP & Chief Innovation Officer
|
Tax withholdingHumana Common | 2,528 | $218.82 | $553,170.64 |
DisclosureSEC source: 0000049071-17-000089 · edgar.xml · nonDerivative · entry 2 KAY CHRISTOPHER E · CIK 0001602570 · SVP & Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,361 Read SEC document |
| March 17, 2017 Filed Mar 27, 2017 14:22 UTC Amendment |
Kay Christopher E.SVP & Chief Innovation Officer
|
Exercise / conversionHumana Common | 6,186 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000089 · edgar.xml · nonDerivative · entry 1 KAY CHRISTOPHER E · CIK 0001602570 · SVP & Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,889 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · balance_after: Includes both time based (2,929) and performance based (3,257) restricted stock units that vested on 3/17/17. Amendment filed to correct a scrivener's error in the reported number of performance based shares that vested. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 22:45 UTC |
Christopher M TodoroffSr. VP and General Counsel
|
GrantRestricted Stock Units · Derivative | 3,564 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000079 · edgar.xml · derivative · entry 6 Christopher M Todoroff · CIK 0001441437 · Sr. VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,564 Underlying: Humana Common · 3,564 shares Expires not disclosed F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 03/08/2017, vesting in three annual increments. F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 03/08/2017, vesting in three annual increments. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 22:45 UTC |
Christopher M TodoroffSr. VP and General Counsel
|
GrantOptions · Derivative | 15,498 | $0.00 Strike: $217.42 | $0.00 |
DisclosureSEC source: 0000049071-17-000079 · edgar.xml · derivative · entry 4 Christopher M Todoroff · CIK 0001441437 · Sr. VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,498 Underlying: Humana Common · 15,498 shares Expires 2024-03-08 F3 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017, vesting in three annual increments. F3 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017, vesting in three annual increments. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 22:37 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
GrantRestricted Stock Units · Derivative | 21,272 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000078 · edgar.xml · derivative · entry 6 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,272 Underlying: Humana Common · 21,272 shares Expires not disclosed F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_date: Restricted stock units granted to reporting person on 03/08/2017,vesting in three annual increments. F6 · derivative.expiration_date: Restricted stock units granted to reporting person on 03/08/2017,vesting in three annual increments. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 22:37 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
GrantOptions · Derivative | 92,489 | $0.00 Strike: $217.42 | $0.00 |
DisclosureSEC source: 0000049071-17-000078 · edgar.xml · derivative · entry 4 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,489 Underlying: Humana Common · 92,489 shares Expires 2024-03-08 F3 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017, vesting in three annual increments. F3 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017, vesting in three annual increments. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 22:34 UTC |
LeClaire Brian P.SVP & Chief Information Off.
|
GrantRestricted Stock Units · Derivative | 5,346 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000077 · edgar.xml · derivative · entry 7 LeClaire Brian P. · CIK 0001528285 · SVP & Chief Information Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,346 Underlying: Humana Common · 5,346 shares Expires not disclosed F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 03/08/2017, 3,564 shares vesting in three annual increments, and 1,782 shares fully vest three years from the date of grant. F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 03/08/2017, 3,564 shares vesting in three annual increments, and 1,782 shares fully vest three years from the date of grant. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 22:34 UTC |
LeClaire Brian P.SVP & Chief Information Off.
|
GrantOptions · Derivative | 23,247 | $0.00 Strike: $217.42 | $0.00 |
DisclosureSEC source: 0000049071-17-000077 · edgar.xml · derivative · entry 5 LeClaire Brian P. · CIK 0001528285 · SVP & Chief Information Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,247 Underlying: Humana Common · 23,247 shares Expires 2024-03-08 F4 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 15,498 options vesting in three annual increments, and 7,749 options fully vest three years from the date of grant. F4 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 15,498 options vesting in three annual increments, and 7,749 options fully vest three years from the date of grant. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 22:28 UTC |
Kay Christopher E.SVP & Chief Innovation Officer
|
GrantRestricted Stock Units · Derivative | 2,529 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000075 · edgar.xml · derivative · entry 7 KAY CHRISTOPHER E · CIK 0001602570 · SVP & Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,529 Underlying: Humana Common · 2,529 shares Expires not disclosed F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 03/08/2017, vesting in three annual increments. F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 03/08/2017, vesting in three annual increments. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 22:28 UTC |
Kay Christopher E.SVP & Chief Innovation Officer
|
GrantOptions · Derivative | 10,998 | $0.00 Strike: $217.42 | $0.00 |
DisclosureSEC source: 0000049071-17-000075 · edgar.xml · derivative · entry 4 KAY CHRISTOPHER E · CIK 0001602570 · SVP & Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,998 Underlying: Humana Common · 10,998 shares Expires 2024-03-08 F3 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017, vesting in three annual increments. F3 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017, vesting in three annual increments. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 22:31 UTC |
MARGULIS HEIDI SSenior V.P. -Corporate Affairs
|
GrantRestricted Stock Units · Derivative | 4,483 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000076 · edgar.xml · derivative · entry 7 MARGULIS HEIDI S · CIK 0001103605 · Senior V.P. -Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,483 Underlying: Humana Common · 4,483 shares Expires not disclosed F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 03/08/2017, 2,989 shares vesting in three annual increments, and 1,494 shares fully vest three years from the date of grant. F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 03/08/2017, 2,989 shares vesting in three annual increments, and 1,494 shares fully vest three years from the date of grant. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 22:31 UTC |
MARGULIS HEIDI SSenior V.P. -Corporate Affairs
|
GrantOptions · Derivative | 19,497 | $0.00 Strike: $217.42 | $0.00 |
DisclosureSEC source: 0000049071-17-000076 · edgar.xml · derivative · entry 5 MARGULIS HEIDI S · CIK 0001103605 · Senior V.P. -Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,497 Underlying: Humana Common · 19,497 shares Expires 2024-03-08 F3 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 12,998 options vesting in three annual increments, and 6,499 options fully vest three years from the date of grant. F3 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 12,998 options vesting in three annual increments, and 6,499 options fully vest three years from the date of grant. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 22:24 UTC |
Kane Brian ASVP & Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 6,898 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000074 · edgar.xml · derivative · entry 7 Kane Brian A · CIK 0001609525 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,898 Underlying: Humana Common · 6,898 shares Expires not disclosed F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 03/08/2017, 4,599 shares vesting in three annual increments, and 2,299 shares fully vest three years from the date of grant. F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 03/08/2017, 4,599 shares vesting in three annual increments, and 2,299 shares fully vest three years from the date of grant. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 22:24 UTC |
Kane Brian ASVP & Chief Financial Officer
|
GrantOptions · Derivative | 29,995 | $0.00 Strike: $217.42 | $0.00 |
DisclosureSEC source: 0000049071-17-000074 · edgar.xml · derivative · entry 4 Kane Brian A · CIK 0001609525 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,995 Underlying: Humana Common · 29,995 shares Expires 2024-03-08 F3 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 19,997 options vesting in three annual increments, and 9,998 options fully vest three years from the date of grant. F3 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 19,997 options vesting in three annual increments, and 9,998 options fully vest three years from the date of grant. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 22:20 UTC |
HUNTER CHRISTOPHER H.SVP and Chief Strategy Officer
|
GrantRestricted Stock Units · Derivative | 4,483 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000073 · edgar.xml · derivative · entry 7 HUNTER CHRISTOPHER H. · CIK 0001595519 · SVP and Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,483 Underlying: Humana Common · 4,483 shares Expires not disclosed F5 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3) under Company's 2011 Plan. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3) under Company's 2011 Plan. F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 03/08/2017, 2,989 shares vesting in three annual increments, and 1,494 shares fully vest three years from the date of grant. F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 03/08/2017, 2,989 shares vesting in three annual increments, and 1,494 shares fully vest three years from the date of grant. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 22:20 UTC |
HUNTER CHRISTOPHER H.SVP and Chief Strategy Officer
|
GrantOptions · Derivative | 19,497 | $0.00 Strike: $217.42 | $0.00 |
DisclosureSEC source: 0000049071-17-000073 · edgar.xml · derivative · entry 5 HUNTER CHRISTOPHER H. · CIK 0001595519 · SVP and Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,497 Underlying: Humana Common · 19,497 shares Expires 2017-03-08 F4 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 12,998 options vesting in three annual increments, and 6,499 options fully vest three years from the date of grant. F4 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 12,998 options vesting in three annual increments, and 6,499 options fully vest three years from the date of grant. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 22:17 UTC |
Zipperle Cynthia HVice President, CAO,Controller
|
GrantRestricted Stock Units · Derivative | 3,345 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000072 · edgar.xml · derivative · entry 6 Zipperle Cynthia H · CIK 0001628102 · Vice President, CAO,Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,345 Underlying: Humana Common · 3,345 shares Expires not disclosed F3 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F3 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_date: Restricted stock units granted to reporting person on 03/08/2017, 2,230 shares vesting in three annual increments, and 1,115 shares fully vest three years from the date of grant. F6 · derivative.expiration_date: Restricted stock units granted to reporting person on 03/08/2017, 2,230 shares vesting in three annual increments, and 1,115 shares fully vest three years from the date of grant. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 22:09 UTC |
BILNEY JODY LSVP & Chief Consumer Officer
|
GrantRestricted Stock Units · Derivative | 5,346 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000071 · edgar.xml · derivative · entry 7 BILNEY JODY L · CIK 0001185995 · SVP & Chief Consumer Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,346 Underlying: Humana Common · 5,346 shares Expires not disclosed F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 03/08/2017, 3,564 shares vesting in three annual increments, and 1,782 shares fully vest three years from the date of grant. F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 03/08/2017, 3,564 shares vesting in three annual increments, and 1,782 shares fully vest three years from the date of grant. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 22:09 UTC |
BILNEY JODY LSVP & Chief Consumer Officer
|
GrantOptions · Derivative | 23,247 | $0.00 Strike: $217.42 | $0.00 |
DisclosureSEC source: 0000049071-17-000071 · edgar.xml · derivative · entry 5 BILNEY JODY L · CIK 0001185995 · SVP & Chief Consumer Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,247 Underlying: Humana Common · 23,247 shares Expires 2024-03-08 F4 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 15,498 options vesting in three annual increments, and 7,749 options fully vest three years from the date of grant. F4 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 15,498 options vesting in three annual increments, and 7,749 options fully vest three years from the date of grant. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 22:06 UTC |
Huval Timothy S.Senior VP & Chief HR Officer
|
GrantRestricted Stock Units · Derivative | 5,346 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000070 · edgar.xml · derivative · entry 6 Huval Timothy S. · CIK 0001565717 · Senior VP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,346 Underlying: Humana Common · 5,346 shares Expires not disclosed F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_date: Restricted stock units granted to reporting person on 03/08/2017, 3,564 shares vesting in three annual increments, and 1,782 shares fully vest three years from the date of grant. F6 · derivative.expiration_date: Restricted stock units granted to reporting person on 03/08/2017, 3,564 shares vesting in three annual increments, and 1,782 shares fully vest three years from the date of grant. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 22:06 UTC |
Huval Timothy S.Senior VP & Chief HR Officer
|
GrantOptions · Derivative | 23,247 | $0.00 Strike: $217.42 | $0.00 |
DisclosureSEC source: 0000049071-17-000070 · edgar.xml · derivative · entry 4 Huval Timothy S. · CIK 0001565717 · Senior VP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,247 Underlying: Humana Common · 23,247 shares Expires 2024-03-08 F3 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 15,498 options vesting in three annual increments, and 7,749 options fully vest three years from the date of grant. F3 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 15,498 options vesting in three annual increments, and 7,749 options fully vest three years from the date of grant. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 21:58 UTC |
BEVERIDGE, ROY ASr. VP & Chief Medical Officer
|
GrantRestricted Stock Units · Derivative | 3,678 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000069 · edgar.xml · derivative · entry 8 BEVERIDGE, ROY A · CIK 0001579300 · Sr. VP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,678 Underlying: Humana Common · 3,678 shares Expires not disclosed F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 03/08/2017, 2,529 shares vesting in three annual increments, and 1,149 shares fully vest three years from the date of grant. F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 03/08/2017, 2,529 shares vesting in three annual increments, and 1,149 shares fully vest three years from the date of grant. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 21:58 UTC |
BEVERIDGE, ROY ASr. VP & Chief Medical Officer
|
GrantOptions · Derivative | 15,997 | $0.00 Strike: $217.42 | $0.00 |
DisclosureSEC source: 0000049071-17-000069 · edgar.xml · derivative · entry 6 BEVERIDGE, ROY A · CIK 0001579300 · Sr. VP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,997 Underlying: Humana Common · 15,997 shares Expires 2024-03-08 F4 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 10,998 options vesting in three annual increments, and 4,999 options fully vest three years from the date of grant. F4 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 10,998 options vesting in three annual increments, and 4,999 options fully vest three years from the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.